BSGM (BioSig Technologies) FCF Margin % : 0.00% (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is BioSig Technologies FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BioSig Technologies's Free Cash Flow for the three months ended in Sep. 2024 was $-1.49 Mil. BioSig Technologies's Revenue for the three months ended in Sep. 2024 was $0.00 Mil. Therefore, BioSig Technologies's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

As of today, BioSig Technologies's current FCF Yield % is -28.54%.

The historical rank and industry rank for BioSig Technologies's FCF Margin % or its related term are showing as below:

BSGM' s FCF Margin % Range Over the Past 10 Years
Min: -97216.67 Med: -7647.9 Max: -6109.07
Current: -18538.46

During the past 11 years, the highest FCF Margin % of BioSig Technologies was -6109.07%. The lowest was -97216.67%. And the median was -7647.90%.

BSGM's FCF Margin % is ranked worse than
99.39% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: -4.42 vs BSGM: -18538.46

BioSig Technologies FCF Margin % Historical Data

The historical data trend for BioSig Technologies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioSig Technologies FCF Margin % Chart

BioSig Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-6,109.07

-7,647.90

-97,216.67

BioSig Technologies Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															-388,800.00	-24,550.00	-9,385.71	-11,392.31	-

Competitive Comparison of BioSig Technologies's FCF Margin %

For the Medical Devices subindustry, BioSig Technologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioSig Technologies's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BioSig Technologies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BioSig Technologies's FCF Margin % falls into.

BioSig Technologies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BioSig Technologies's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-17.499	/	0.018
	=	-97,216.67 %

BioSig Technologies's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-1.489	/	0
	=	%

BioSig Technologies FCF Margin % Related Terms

Thank you for viewing the detailed overview of BioSig Technologies's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

BioSig Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioSig Technologies Inc (NAS:BSGM) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

55 Greens Farms Road, 1st Floor, Westport, CT, USA, 06880

Website

https://www.biosig.com

BioSig Technologies Inc is a commercial-stage medical device company with an advanced digital signal processing technology platform to deliver insights to the treatment of cardiovascular arrhythmias. Through collaboration with physicians, experts, and healthcare leaders across the field of electrophysiology (EP), It is committed to addressing healthcare's biggest priorities saving time, saving costs, and saving lives. Its first product, the PURE EP System, is an FDA-cleared non-invasive class II device consisting of a unique combination of hardware and software designed to provide unprecedented signal clarity and precision for real-time visualization of intracardiac signals paving the way for personalized patient care.

Executives

Kenneth L Londoner	director, 10 percent owner	10 RED COAT ROAD, WESTPORT CT 06880
Steven J Buhaly	officer: Chief Financial Officer	1195 NW LOMPTON DRIVE, BEAVESTON OR 97006
John Sieckhaus	officer: Chief Operating Officer	C/O BIOSIG TECHNOLOGIES, 55 GREENS FARMS ROAD, WESTPORT CT 06880
Steve Chaussy	officer: Chief Financial Officer	9780 E AVE, HESPERIA CA 92345
Patrick Joseph Gallagher	director	275 PLEASANT HILL RD., FLANDERS NJ 07836
Gray Fleming	officer: Chief Commercial Officer	C/O BIOSIG TECHNOLOGIES, INC., 55 GREENS FARMS ROAD, WESTPORT CT 06880
James L Klein	director	2300NE BROOKWOOD PKWY, HILLSBORO OR 97124
Frederick Hrkac	director	C/O BIOSIG TECHNOLOGIES, 55 GREENS FARMS ROAD, WESTPORT CT 06880
James J Barry	director	C/O INSPIREMD, INC., 4 MENORAT HAMAOR ST., TEL AVIV L3 6744832
Jeffrey F Odonnell	director	126 ROSSMORE DRIVE, MALVERN PA 19355
Anthony P. Zook	director	C/O VIVUS, INC., 351 EAST EVELYN AVENUE, MOUNTAIN VIEW CA 94041
Jerome B Zeldis	director	8767 E. VIA DE VENTURA, SUITE 190, SCOTTSDALE AZ 85258
Martha Pease	director	33 SEAVIEW, MADISON CT 06443
John M Kowalski	officer: VP of Sales	54 WILTON ROAD, 2ND FLOOR, WESTPORT CT 06880
Samuel E Navarro	director	C/O STRATA SKIN SCIENCES, INC., 5 WALNUT GROVE DRIVE, SUITE 140, HORSHAM PA 19044